PDL1 expression has been studied in different cancers such as kidney, lung, pancreas, esophagus, ovary, colorectal, head and neck and squamous cell carcinomas, melanomas and gliomas [22-32], with evidence of correlations with clinicopathological tumor features in several studies. Here, CD274 is linked to neoplasm.